Evidence map›Paper›PMID 32040340›Full record

Observational studyAnnals of the American Thoracic Society2020

Associations between Patient-reported Outcomes and Death or Lung Transplant in Idiopathic Pulmonary Fibrosis. Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry.

Amy Hajari Case, Anne S Hellkamp, Megan L Neely, Shaun Bender, Daniel F Dilling, Mridu Gulati, David L Hotchkin, Tristan J Huie, Lisa Lancaster, Laurie D Snyder and 2 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Annals of the American Thoracic Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 3 pooled it
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 3 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis.European respiratory review : an official journal of the European Respiratory Society · 2020
    Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Management of patients with fibrosing interstitial lung diseases.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2022
    Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 1 country.

Amy Hajari CasePiedmont Healthcare, Atlanta, Georgia.ORCID 0000-0001-8663-2022
Anne S HellkampDuke Clinical Research Institute, Durham, North Carolina.
Megan L NeelyDuke Clinical Research Institute, Durham, North Carolina.
Shaun BenderBoehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut.
Daniel F DillingDivision of Pulmonary and Critical Care, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois.ORCID 0000-0002-9723-510X
Mridu GulatiYale School of Medicine, New Haven, Connecticut.
David L HotchkinDivision of Pulmonary, Critical Care & Sleep Medicine, The Oregon Clinic, Portland, Oregon.
Tristan J HuieNational Jewish Health, Denver, Colorado; and.
Lisa LancasterVanderbilt University Medical Center, Nashville, Tennessee.
Laurie D SnyderDuke Clinical Research Institute, Durham, North Carolina.
Craig S ConoscentiBoehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut.
Scott M PalmerDuke Clinical Research Institute, Durham, North Carolina.
Clinical Research Institute · USBoehringer Ingelheim (United States) · USLoyola University Chicago · USNational Jewish Health · USOregon Clinic · USPiedmont HealthCare · USVanderbilt University Medical Center · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Patient Reported Outcome MeasuresAgedDisease ProgressionExerciseFemaleHumansIdiopathic Pulmonary FibrosisLung TransplantationMaleProportional Hazards ModelsProspective StudiesRegistriesSurveys and QuestionnairesUnited Statesinterstitial lung diseasesmortalityobservational studyregistries

Identifiers

PMID32040340
PMCPMC7258421
OpenAlexW3006290889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.